MX2023010211A - Obicetrapib para tratamiento de demencias. - Google Patents
Obicetrapib para tratamiento de demencias.Info
- Publication number
- MX2023010211A MX2023010211A MX2023010211A MX2023010211A MX2023010211A MX 2023010211 A MX2023010211 A MX 2023010211A MX 2023010211 A MX2023010211 A MX 2023010211A MX 2023010211 A MX2023010211 A MX 2023010211A MX 2023010211 A MX2023010211 A MX 2023010211A
- Authority
- MX
- Mexico
- Prior art keywords
- obicetrapib
- dementias
- treatment
- subject
- neurodegenerative disease
- Prior art date
Links
- NRWORBQAOQVYBJ-GJZUVCINSA-N obicetrapib Chemical compound N=1C=C(OCCCC(O)=O)C=NC=1N([C@H]1C[C@@H](CC)N(C2=CC=C(C=C21)C(F)(F)F)C(=O)OCC)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 NRWORBQAOQVYBJ-GJZUVCINSA-N 0.000 title abstract 2
- 229950004285 obicetrapib Drugs 0.000 title abstract 2
- 206010012289 Dementia Diseases 0.000 title 1
- 230000004770 neurodegeneration Effects 0.000 abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
Se presentan métodos para desacelerar la progresión de una enfermedad neurodegenerativa en un sujeto quien tiene o está en riesgo de desarrollar una enfermedad neurodegenerativa. Los métodos comprenden administrar una cantidad terapéuticamente eficaz de obicetrapib o una sal farmacéuticamente aceptable del mismo al sujeto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163157586P | 2021-03-05 | 2021-03-05 | |
PCT/IB2022/000098 WO2022185120A1 (en) | 2021-03-05 | 2022-03-04 | Obicetrapib for treatment of dementias |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2023010211A true MX2023010211A (es) | 2023-11-22 |
Family
ID=81327869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023010211A MX2023010211A (es) | 2021-03-05 | 2022-03-04 | Obicetrapib para tratamiento de demencias. |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP4125911B1 (es) |
JP (1) | JP2024513155A (es) |
KR (1) | KR20230159457A (es) |
CN (1) | CN117529319A (es) |
AU (1) | AU2022231417A1 (es) |
BR (1) | BR112023017999A2 (es) |
CA (1) | CA3212483A1 (es) |
DK (1) | DK4125911T3 (es) |
FI (1) | FI4125911T3 (es) |
IL (1) | IL305576A (es) |
MX (1) | MX2023010211A (es) |
WO (1) | WO2022185120A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202409008A (zh) | 2022-07-05 | 2024-03-01 | 荷蘭商新阿姆斯特丹製藥公司 | 奧比特拉(obicetrapib)鹽及彼等之製造方法與中間體 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA90269C2 (ru) * | 2004-04-02 | 2010-04-26 | Мицубиси Танабе Фарма Корпорейшн | Тетрагидрохинолиновые производные и способ их получения |
JP4531027B2 (ja) * | 2005-09-29 | 2010-08-25 | 田辺三菱製薬株式会社 | 医薬組成物 |
TW200808731A (en) | 2006-03-30 | 2008-02-16 | Tanabe Seiyaku Co | A process for preparing tetrahydroquinoline derivatives |
EP2281824A1 (en) * | 2009-08-07 | 2011-02-09 | Noscira, S.A. | Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
WO2012050517A1 (en) * | 2010-10-14 | 2012-04-19 | Astrazeneca Ab | Imidazole substituted pyrimidine having a high gsk3 inhibiting potency as well as pan-kinase selectivity |
BR112016018077A8 (pt) * | 2014-02-05 | 2020-06-23 | Dezima Pharma B V | inibidor de proteína de transferência de éster colesterílico (composto a), composições farmacêuticas compreendendo o mesmo, método para preparação das referidas composições e uso do composto a |
US10112904B2 (en) | 2014-08-12 | 2018-10-30 | Dezima Pharma B.V. | Process for preparing synthetic intermediates for preparing tetrahydroquinoline derivatives |
-
2022
- 2022-03-04 MX MX2023010211A patent/MX2023010211A/es unknown
- 2022-03-04 KR KR1020237033972A patent/KR20230159457A/ko unknown
- 2022-03-04 IL IL305576A patent/IL305576A/en unknown
- 2022-03-04 DK DK22715162.8T patent/DK4125911T3/da active
- 2022-03-04 CA CA3212483A patent/CA3212483A1/en active Pending
- 2022-03-04 AU AU2022231417A patent/AU2022231417A1/en active Pending
- 2022-03-04 EP EP22715162.8A patent/EP4125911B1/en active Active
- 2022-03-04 EP EP24150094.1A patent/EP4368250A2/en active Pending
- 2022-03-04 WO PCT/IB2022/000098 patent/WO2022185120A1/en active Application Filing
- 2022-03-04 BR BR112023017999A patent/BR112023017999A2/pt unknown
- 2022-03-04 FI FIEP22715162.8T patent/FI4125911T3/fi active
- 2022-03-04 JP JP2023553588A patent/JP2024513155A/ja active Pending
- 2022-03-04 CN CN202280025877.9A patent/CN117529319A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN117529319A (zh) | 2024-02-06 |
EP4368250A2 (en) | 2024-05-15 |
DK4125911T3 (da) | 2024-07-15 |
WO2022185120A1 (en) | 2022-09-09 |
IL305576A (en) | 2023-10-01 |
EP4125911A1 (en) | 2023-02-08 |
JP2024513155A (ja) | 2024-03-22 |
CA3212483A1 (en) | 2022-09-09 |
EP4125911B1 (en) | 2024-04-24 |
KR20230159457A (ko) | 2023-11-21 |
BR112023017999A2 (pt) | 2023-11-14 |
AU2022231417A1 (en) | 2023-10-19 |
FI4125911T3 (fi) | 2024-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000538A (es) | Uso de sobetirome en el tratamiento de enfermedades de mielinizacion. | |
MX2022007276A (es) | Tratamiento de la esclerosis amiotrofica lateral y enfermedades relacionadas. | |
EA201490277A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
PH12014502218A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
NI201100147A (es) | Métodos para tratar infartos agudos de miocardio y trastornos relacionados. | |
MX2018006247A (es) | Metodos para tratar la enfermedad de alzheimer y trastornos relacionados. | |
EA201490163A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
MA43828B1 (fr) | Agents thérapeutiques pour maladies neurodégénératives | |
PH12017500444A1 (en) | Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementia | |
BR112022002609A2 (pt) | Métodos de tratamento de tumores estromais gastrointestinais | |
PH12021550043A1 (en) | Use of riluzole prodrugs to treat alzheimer's disease | |
PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
PH12021550218A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
MX2023010211A (es) | Obicetrapib para tratamiento de demencias. | |
MX2022000143A (es) | Metodos novedosos. | |
WO2020128614A8 (en) | Method for treating interstital lung disease | |
RU2016102092A (ru) | Тауроурсодезоксихолевая кислота (tudca) для применения в лечении нейродегенеративных нарушений | |
PH12020550722A1 (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
EA201170970A1 (ru) | Применение деферипрона для лечения и предупреждения заболеваний глаз, связанных с железом | |
EA202193211A1 (ru) | Лечение синуклеопатий | |
MX2021014093A (es) | Composiciones y metodos para tratar el mal de alzheimer y la enfermedad de parkinson. | |
EA202193190A1 (ru) | Композиция, включающая придопидин и его аналог, для лечения болезни гентингтона и ее симптомов | |
EA202090416A1 (ru) | Способы лечения симптомов гастропареза с использованием велусетрага | |
FI3903774T3 (fi) | N,N-bis-2-merkaptoetyyli-isoftalamidi neurodegeneratiivisten sairauksien hoitoon |